Elicio Therapeutics, Inc. · NASDAQ:ELTX
Elicio Therapeutics, Inc. shareholders
As of Sep 30, 2026, 77 institutions reported holding Elicio Therapeutics, Inc., 25.8% of its shares. Largest: Shah Capital Management, Knoll Capital Management, LLC and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Elicio Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Shah Capital Management | 1.25M | 4.4% | new | Oct 9, 2026 |
| Knoll Capital Management, LLC | 1.21M | 4.3% | no change | Nov 16, 2026 |
| Vanguard | 790K | 2.8% | +36,322 | Nov 13, 2026 |
| BlackRock | 740K | 2.6% | −25,746 | Nov 13, 2026 |
| Citadel | 543K | 1.9% | new | Nov 16, 2026 |
| AQR Capital Management LLC | 449K | 1.6% | new | Nov 16, 2026 |
| Geode Capital | 414K | 1.5% | +103K | Nov 6, 2026 |
| Morgan Stanley | 396K | 1.4% | +370K | Nov 13, 2026 |
| UBS | 236K | 0.83% | +196K | Nov 10, 2026 |
| State Street | 232K | 0.82% | +52,822 | Nov 12, 2026 |